Xbrane Biopharma
0.156
SEK
-4.29 %
XBRANE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
8 following
-4.29%
-27.27%
0%
-44.19%
-86.24%
-83.6%
-98.6%
-96.03%
-95.91%
Xbrane Biopharma is a biotechnology company. The company specializes in research and development of drugs for the treatment of critical illnesses. Today, the business is focused on research in microspherical technology and in the development of protein molecules. The products are used in the treatment of prostate cancer and endometriosis, as well as in rare and serious eye diseases. The company's head office is located in Solna.
Read moreMarket cap
239.02M SEK
Turnover
936.64K SEK
Revenue
238.73M
EBIT %
-134.95 %
P/E
-
Dividend yield-%
-
Financial calendar
21/2
2025
Annual report '24
5/5
2025
General meeting '24
8/5
2025
Interim report Q1'25
ShowingAll content types
Xbrane announces outcome of exercise of warrants of series TO1
XBRANE BIOPHARMAS HUVUDÄGARE SYSTEMATIC GROUP GER KORTSIKTIGT LÅN PÅ 20 MSEK TILL BOLAGET
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools